Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (31-40 of 715) with videos related to

Pageof 72
Sort By:
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1992
[Forms of cooperation between industry and university]D Collen
Acta Clinica Belgica|January 1, 1977
Thrombin-antithrombin III and plasmin-antiplasmin complexes as indicators of in vivo activation of the coagulation and/or fibrinolytic systemsD Collen
Thrombosis and Haemostasis|December 22, 1999
The plasminogen (fibrinolytic) systemD Collen
European Journal of Biochemistry|October 1, 1976
Identification and some properties of a new fast-reacting plasmin inhibitor in human plasmaD Collen
Thrombosis and Haemostasis|October 31, 1983
Mechanisms of inhibition of tissue-type plasminogen activator in bloodD Collen
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1982
[Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent]D Collen
Circulation|July 1, 1985
Human tissue-type plasminogen activator: from the laboratory to the bedsideD Collen
Drugs|January 1, 1986
Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease statesD Collen
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1991
Thrombolytic therapy of acute myocardial infarctionD Collen
Texas Heart Institute Journal|December 1, 1984
Coronary thrombolysis with tissue-type plasminogen activator: prospective reviewD Collen D
Pageof 72

Showing results (31-40 of 715) with videos related to

Sort By:
Pageof 72
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1992
[Forms of cooperation between industry and university]D Collen
Acta Clinica Belgica|January 1, 1977
Thrombin-antithrombin III and plasmin-antiplasmin complexes as indicators of in vivo activation of the coagulation and/or fibrinolytic systemsD Collen
Thrombosis and Haemostasis|December 22, 1999
The plasminogen (fibrinolytic) systemD Collen
European Journal of Biochemistry|October 1, 1976
Identification and some properties of a new fast-reacting plasmin inhibitor in human plasmaD Collen
Thrombosis and Haemostasis|October 31, 1983
Mechanisms of inhibition of tissue-type plasminogen activator in bloodD Collen
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1982
[Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent]D Collen
Circulation|July 1, 1985
Human tissue-type plasminogen activator: from the laboratory to the bedsideD Collen
Drugs|January 1, 1986
Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease statesD Collen
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1991
Thrombolytic therapy of acute myocardial infarctionD Collen
Texas Heart Institute Journal|December 1, 1984
Coronary thrombolysis with tissue-type plasminogen activator: prospective reviewD Collen D
Pageof 72